The Australian Genome Foundry (AGF) is developing a novel approach to improve the production of psilocybin, an emerging therapeutic compound being investigated for conditions including treatment-resistant depression, substance dependence and end-of-life anxiety....
When Rosie, a seven-year-old rescue dog, was diagnosed with an aggressive and incurable form of mast cell cancer, her owner turned to genomics in search of another option. Working with the Ramaciotti Centre for Genomics at UNSW Sydney, Rosie’s tumour and healthy...
Bioplatforms Australia is proud to partner with Therapeutic Innovation Australia (TIA), Microscopy Australia, Phenomics Australia, and ANSTO’s National Deuteration Facility (NDF) to support translational medical research through the Pipeline Accelerator voucher...
Proteomics International has reached a major milestone in the development and commercialisation of PromarkerEndo, receiving a notice of acceptance from IP Australia for a patent covering its proprietary blood test for the diagnosis of endometriosis. The Australian...
The Australian Functional Fungi Initiative is now seeking partnerships to create foundational biomolecular data resources to fast-track knowledge and innovation of Australian Fungi. NOTE: Due to Bioplatforms Australia’s prior investment in the Plant Pathogen Omics...
Key Points 1. The aim of this Voucher Scheme is to enable projects addressing significant scientific challenges using synthetic biology capabilities at NCRIS SynBio and NCRIS Partner facilities. 2. Applications for a Primary Voucher will include a Lead Provider from...
